News
Cardiac intensive care units are witnessing a demographic shift, characterized by patients with increasingly complex or ...
About PYRUKYND® (mitapivat) U.S. INDICATION PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback